CohBar
engaged in the research and development of mitochondria-based therapeutics... Read moreCohBar
engaged in the research and development of mitochondria-based therapeutics... Read more
CEO
Joseph J. Sarret
2007
PublicMerger Pending with Morphogenesis, IncNASDAQCWBR
News
Nov 27, 2023
Acrofan
CohBar: CohBar, Inc.: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing (Form 8-K)
Nov 01, 2023
MarketScreener
CohBar: CohBar : Termination of Material Agreement - Form 8-K
Aug 14, 2023
GlobeNewswire
Press Release: CohBar : CohBar Reports Second Quarter 2023 Financial Results
Jul 19, 2023
GlobalNewswire
Press Release: CohBar : Moore Kuehn Encourages CWBR, KDNY, GHL, and EMAN Investors to Contact Law Firm
Jun 05, 2023
Benzinga
CohBar: CohBar's Acquisition Partner Touts Encouraging Data From Personalized Cancer Vaccine
May 31, 2023
MarketScreener
CohBar: COHBAR INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of CohBar, Inc. - CWBR
May 31, 2023
Picante Today
CohBar: COHBAR INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of CohBar, Inc. - CWBR
May 23, 2023
Endpoints News
CohBar: CohBar, Morphogenesis link up in reverse merger of two cancer biotechs
Dec 07, 2022
MarketScreener
CohBar: CohBar : Current Report - Form 8-K
Nov 11, 2022
Seeking Alpha
CohBar: CohBar, Inc. (CWBR) Q3 2022 Earnings Call Transcript